The European Commission granted a label expansion for GSK's (GSK.L) Arexvy, authorizing the use of the adjuvanted recombinant respiratory syncytial virus vaccine for adults aged 18 years and above, ...
In the modern dental landscape, the "lone wolf" dentist is no longer a sustainable business model. High-growth practices have transitioned to a provider-centric structure, where clinical duties are ...
An internal memo changed the standard from whether people are unlikely to show up for hearings to whether they could leave the scene. By Hamed Aleaziz and Charlie Savage Reporting from Washington Amid ...
Nearly 6,500 Arizona children have applied for the new universal vouchers to attend private and parochial schools at taxpayer expense. And it appears the vast majority are students whose parents ...
PETALING JAYA: The government will announce a more comprehensive use of the Central Database Hub (Padu) system by early March, says economy minister Akmal Nasrullah Nasir. He said Putrajaya is ...
GSK plc GSK announced that the European Commission has approved its blockbuster respiratory drug, Nucala (mepolizumab), for treating certain patients with chronic obstructive pulmonary disease (COPD), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results